56 related articles for article (PubMed ID: 31485668)
1. Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.
Kievit FM; Wang K; Ozawa T; Tarudji AW; Silber JR; Holland EC; Ellenbogen RG; Zhang M
Nanomedicine; 2017 Oct; 13(7):2131-2139. PubMed ID: 28614736
[TBL] [Abstract][Full Text] [Related]
2. Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.
Kozielski KL; Ruiz-Valls A; Tzeng SY; Guerrero-Cázares H; Rui Y; Li Y; Vaughan HJ; Gionet-Gonzales M; Vantucci C; Kim J; Schiapparelli P; Al-Kharboosh R; Quiñones-Hinojosa A; Green JJ
Biomaterials; 2019 Jul; 209():79-87. PubMed ID: 31026613
[TBL] [Abstract][Full Text] [Related]
3. Expression of concern: A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma.
Xie Y; Lu X; Wang Z; Liu M; Liu L; Wang R; Yang K; Xiao H; Li J; Tang X; Liu H
Biomater Sci; 2024 Jun; 12(12):3238. PubMed ID: 38808535
[TBL] [Abstract][Full Text] [Related]
4. Dual Drug Repurposing: The Example of Saracatinib.
Ramos R; Vale N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674150
[TBL] [Abstract][Full Text] [Related]
5. Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery.
Teng XQ; Qu J; Li GH; Zhuang HH; Qu Q
Front Cell Dev Biol; 2022; 10():824299. PubMed ID: 35874843
[TBL] [Abstract][Full Text] [Related]
6.
Cirotti C; Contadini C; Barilà D
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545574
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems.
Mirzaei S; Mahabady MK; Zabolian A; Abbaspour A; Fallahzadeh P; Noori M; Hashemi F; Hushmandi K; Daneshi S; Kumar AP; Aref AR; Samarghandian S; Makvandi P; Khan H; Hamblin MR; Ashrafizadeh M; Zarrabi A
Life Sci; 2021 Jun; 275():119368. PubMed ID: 33741417
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of STAT3‑targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo.
Liu Q; Wang L; Li D; Zhao J; Chen S; Li J
Mol Med Rep; 2019 Oct; 20(4):3625-3632. PubMed ID: 31485668
[TBL] [Abstract][Full Text] [Related]
9. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
[TBL] [Abstract][Full Text] [Related]
10. Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.
Wu J; Feng X; Zhang B; Li J; Xu X; Liu J; Wang X; Wang J; Tong X
J Neurooncol; 2014 Oct; 120(1):33-41. PubMed ID: 25048528
[TBL] [Abstract][Full Text] [Related]
11. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract][Full Text] [Related]
13. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] IL‑8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF‑κB pathway in prostate cancer.
Guo Y; Zang Y; Lv L; Cai F; Qian T; Zhang G; Feng Q
Mol Med Rep; 2019 Apr; 19(4):2970. PubMed ID: 30816455
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
